Cellosaurus cell line PER-909 (CVCL

Cellosaurus PER-909 (CVCL_C9CN)

Cross-references
Cell line name	PER-909
Synonyms	P896-CL
Accession	CVCL_C9CN
Resource Identification Initiative	To cite this cell line use: PER-909 (RRID:CVCL_C9CN)
Comments	Omics: Genomics; Whole exome sequencing. Omics: Transcriptomics; RNAseq. Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
Sequence variations	Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 15 fused to NUTM1 exon 2 (PubMed=26551281).
Disease	NUT carcinoma (NCIt: C45716) NUT midline carcinoma (ORDO: Orphanet_443167)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual	CVCL_C9CP ! PER-904N
Sex of cell	Female
Age at sampling	14Y
Category	Cancer cell line
Publications	PubMed=26551281; DOI=10.1038/oncsis.2015.33; PMCID=PMC4670959 Anja Stirnweiss, K. McCarthy, Joyce Oommen, Maxine L. Crook, Kate Hardy, Ursula R. Kees, Stephen Donald Wilton, Antoinette Catherine Anazodo, Alex H. Beesley; A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma. Oncogenesis 4:e174.1-e174.5(2015) PubMed=29348827; DOI=10.18632/oncotarget.22862; PMCID=PMC5762512 Anja Stirnweiss, Joyce Oommen, Rishi S. Kotecha, Ursula R. Kees, Alex H. Beesley; Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease. Oncotarget 8:112313-112329(2017)
Encyclopedic resources	Wikidata; Q123033267
Entry history
Entry creation	05-Oct-2023
Last entry update	10-Apr-2025
Version number	4